You are here

Celegene

Will Access and Label Expansion Drive Celgene’s Otezla Growth?

Yahoo/Market Realist

Fri, 03/18/16 - 10:37 am

Celgene names Mark Alles to CEO position, ending internal contest

Fierce Biotech

Sun, 01/17/16 - 12:14 pm

Eyeing buyout, Celgene paying $105M to partner on Lycera's anti-cancer T cell tech

Fierce Biotech

Tue, 06/9/15 - 12:00 pm

Analysis of FDA side-effect reports flags Sanofi, Celgene meds

Fierce Pharma

Tue, 01/28/14 - 11:37 am

Celgene's And Osiris' IP Positions Weakened By Pluristem's Pivotal Patent

Seeking Alpha

Thu, 09/12/13 - 10:20 am

placental-based cells

Celgene Riding Molecular Biology 'Revolution': CEO

CNBC

Fri, 04/13/12 - 09:56 am

molecular biology

Celgene to Issue $1.25 Billion of Debt in Debut Sale After Boosting Size

Bloomberg

Mon, 10/4/10 - 07:46 pm

NICE deal, Celegene

InVivo

Tue, 02/10/09 - 08:27 am